Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
Reserves | 1,504.89 | 1,263.64 | 975.46 | 822.67 | 768.98 |
Equity Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 1,517.79 | 1,276.54 | 988.36 | 835.57 | 781.88 |
Secured Loans | 90.73 | 44.92 | 121.51 | 196.46 | 145.12 |
Unsecured Loans | 66.41 | 50.47 | 6.94 | 44.07 | 37.18 |
Total Debt | 157.14 | 95.39 | 128.45 | 240.53 | 182.30 |
Other Liabilities | 6.64 | 7.13 | 9.83 | 11.45 | 11.96 |
Total Liabilities | 1,681.57 | 1,379.06 | 1,126.64 | 1,087.55 | 976.14 |
APPLICATION OF FUNDS : | |||||
Gross Block | 1,238.17 | 1,092.86 | 972.58 | 936.15 | 845.36 |
Less: Accumulated Depreciation | 283.28 | 269.21 | 215.05 | 168.79 | 129.53 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 954.89 | 823.65 | 757.53 | 767.36 | 715.83 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 47.66 | 45.89 | 40.57 | 20.46 | 17.25 |
Investments | 109.37 | 1.44 | 0.68 | 4.03 | 7.05 |
Current Assets, Loans & Advances | |||||
Inventories | 385.76 | 350.42 | 279.23 | 265.21 | 247.61 |
Sundry Debtors | 315.72 | 373.53 | 361.77 | 234.33 | 217.73 |
Cash and Bank Balance | 257.27 | 115.29 | 58.65 | 18.99 | 18.08 |
Loans and Advances | 71.39 | 80.23 | 60.69 | 57.35 | 58.30 |
Total Current Assets | 1,030.13 | 919.47 | 760.34 | 575.87 | 541.73 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 422.94 | 390.89 | 383.50 | 237.57 | 287.75 |
Provisions | 2.10 | 1.64 | 11.89 | 1.21 | 0.64 |
Total CL & Provisions | 425.04 | 392.53 | 395.39 | 238.78 | 288.39 |
Net Current Assets | 605.09 | 526.94 | 364.95 | 337.09 | 253.34 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 3.34 | 12.71 | 13.52 | 16.73 | 10.42 |
Deferred Tax Liability | 74.90 | 72.05 | 70.82 | 72.51 | 69.42 |
Net Deferred Tax | -71.56 | -59.34 | -57.30 | -55.78 | -59.00 |
Other Assets | 36.11 | 40.48 | 20.21 | 14.40 | 41.66 |
Total Assets | 1,681.56 | 1,379.07 | 1,126.64 | 1,087.56 | 976.13 |
Contingent Liabilities | 8.97 | 27.73 | 91.21 | 74.68 | 104.71 |